Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000221940 | SCV000271453 | pathogenic | Rare genetic deafness | 2015-08-26 | criteria provided, single submitter | clinical testing | The p.Ile742fs variant in SLC26A4 has not been previously reported in individual s with hearing loss or Pendred syndrome and it was absent from large population studies. This frameshift variant is predicted to alter the protein?s amino acid sequence beginning at position 742 and lead to a premature termination codon 2 a mino acids downstream, which is predicted to lead to a truncated or absent prote in. In summary, this variant meets our criteria to be classified as pathogenic f or hearing loss in an autosomal recessive manner based on its predicted impact. |
Invitae | RCV001043382 | SCV001207126 | pathogenic | not provided | 2019-02-18 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in SLC26A4 are known to be pathogenic (PMID: 16283880, 25394566, 26252218, 26445815). This variant has not been reported in the literature in individuals with SLC26A4-related conditions. ClinVar contains an entry for this variant (Variation ID: 228397). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ile742Phefs*2) in the SLC26A4 gene. It is expected to result in an absent or disrupted protein product. |
Genome- |
RCV001785519 | SCV002026978 | pathogenic | Pendred syndrome | 2021-09-05 | criteria provided, single submitter | clinical testing |